Compounds targeting STEAP-1 ion channel or BPC-1 secreted protein regulatory update

Agensys received U.S. Patents Nos. 6,329,503 and 6,277,972. The ‘503 patent covers STEAP-1, which is a cell surface ion channel overexpressed in prostate cancer patients. Patent ‘972 covers BPC-1 and ...